Latest filing published 26 Jan 2021 for Alligator Bioscience AB, €84k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Per Norlén: trading record in brief
Per Norlén discloses dealings in Alligator Bioscience AB to Finansinspektionen. Between 15 May 2018 and 26 January 2021, the trades on record add up to 4 filings.
The open-market record is one-sided, with 3 purchases worth €114k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant. Since January 2021: 1 purchase and no sales on the market.
Half of the purchases are above €21k and half below.
On 26 January 2021 came the latest disclosure, an open-market purchase for €84k in Alligator Bioscience AB. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 1 day. The regulation allows three business days to notify a trade (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Per Norlén
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 141,600 shares@ SEK 6.00BTA (betald tecknad aktie)ISIN SE0000767188FI:csv-62e9805dbe821836cf51Canonical exit: 26 Apr 2021 (T+90)
- 7,500 shares@ SEK 11.07AktieISIN SE0000767188FI:csv-18dfea57715d2fc49db6Canonical exit: 21 Nov 2019 (T+90)
- 10,000 shares@ SEK 22.04AktieISIN SE0000767188FI:csv-dc61c12fc2a0cd12164cCanonical exit: 28 Mar 2019 (T+90)
- 230,000 shares0FI:csv-0d15a7e3b6c291ef51a0
4 of 4 declarations